Brentuximab Vedotin Administered Concurrently with Multi-Agent Chemotherapy As Frontline Treatment of ALCL and Other CD3O-Positive Mature T-Cell and NK-Cell Lymphomas 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) Fanale, M. A., Shustov, A. R., Forero-Torres, A., Bartlett, N. L., Advani, R. H., Pro, B., Chen, R. W., Davies, A., Midge, T., Kennedy, D. A., Horwitz, S. M. AMER SOC HEMATOLOGY. 2012

View details for Web of Science ID 000313838900104